F2RL3 and acute myeloid leukemia: Additionally, pro-inflammatory signaling (F2RL3 and IL2RA) may interact with transcriptional regulators (SOBP and SIX3) to drive leukemic cell proliferation or hinder normal differentiation, further contributing to AML progression.